Skip to content

Author

K. Ogasawara

We have 3 of 63 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Health-related quality of life in adult patients with moyamoya disease in Japan: a single-center study.

BACKGROUND Moyamoya disease (MMD) is a chronic cerebrovascular disorder associated with stroke and functional impairment that may adversely affect health-related quality of life (HRQOL). This study assessed HRQOL and explored its associated factors in Japanese adults with MMD. RESEARCH DESIGN AND METHODS The 36-Item...

Honoka Tamori, T. Osanai, H. Uchino et al. · 0 citations
#generative ai Open access Sep 2026

Refusal-aware evaluation of frontier AI models available in June 2026 using the Japanese National License Examination for Pharmacists: a comparative study.

Overall accuracy, accuracy excluding refusals, refusal rate, refusal consistency across runs, and refusal consistency describe complementary aspects of performance; therefore, repeated, refusal-aware evaluation is needed to interpret frontier AI models in pharmacy education.

Hiroyasu Sato, K. Ogasawara, Hidehiko Sakurai · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.